Litcius/Paper detail

Bruton’s tyrosine kinase regulates gut immune homeostasis through attenuating Th1 response

Di Guan, Zixi Wang, Jianxin Huo, Shengli Xu, Kong‐Peng Lam

2021Cell Death and Disease13 citationsDOIOpen Access PDF

Abstract

Inflammatory bowel disease (IBD) is driven by multiple genetic and environmental risk factors. Patients with mutations in Bruton's tyrosine kinase (BTK) is known to manifest high prevalence of intestinal disorders including IBD. Although BTK mediates the signaling of various immune receptors, little is known how BTK maintains the homeostasis of the gut immune system. Here, we show that BTK-deficiency promotes IBD progression in a mouse model of colitis. Interestingly, the increased colitis susceptibility of BTK-deficient mice is not caused by gut microbiota changes but rather arises from enhanced pro-inflammatory Th1 response. More importantly, we find the heightened Th1 response in BTK-deficient mice to result from both T cell-extrinsic and -intrinsic mechanisms. BTK-deficient dendritic cells secret elevated levels of the Th1-polarizing cytokine IL-12 and BTK-deficient T cells are inherently more prone to Th1 differentiation. Thus, BTK plays critical roles in maintaining gut immune homeostasis and preventing inflammation via regulating T-cell polarization.

Topics & Concepts

Bruton's tyrosine kinaseImmune systemTyrosine kinaseImmunologyBiologyInflammatory bowel diseaseInflammationHomeostasisSignal transductionCancer researchCell biologyMedicineDiseaseInternal medicineImmune Cell Function and InteractionChronic Lymphocytic Leukemia ResearchImmunodeficiency and Autoimmune Disorders